Harry Porterfield

Professional Titles

• Associate Professor
• Director of Molecular Diagnostics

Publications

• Palmer GW, Dibbern DA Jr, Burks AW, Bannon GA, Bock SA, Porterfield HS, McDermott RA, Dreskin SC. Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol. 2005 Jun;115(3):302-12. PubMed PMID: 15893698
• Porterfield H, Ashby M, Newman WP, McGoey R. Pathology Image of the Month: Mitral Stenosis at Autopsy. J La State Med Soc. 2015 May-Jun;167(3):144-6. PubMed PMID: 27159461
• Singh SB, McLearn-Montz AJ, Milavetz F, Gates LK, Fox C, Murry LT, Sabus A, Porterfield HS, Fischer AJ. Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor. Pediatr Pulmonol. 2019 Aug;54(8):1200-1208. PubMed PMID: 31012285
• Hoover AC, Segal RS, Zimmerman MB, Lee-Son K, Porterfield HS, Stewart SA, Rysavy MA. Urine Trouble: Reducing Midstream Clean Catch Urine Contamination Among Children 3-17 Years Old. Pediatrics. 2021 Aug;148(2). PubMed PMID: 34244453
• Porterfield HS, Maakestad LJ, LaMarche MM, Thurman AL, Kienenberger ZE, Pitcher NJ, Hansen AR, Zirbes CF, Boyken L, Muyskens BL, Pezzulo AA, Singh SB, Twait E, Ford B, Diekema DJ, Reeb V, Fischer AJ. MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis. Pediatr Pulmonol. 2021 Sep;56(9):2868-2878. PubMed PMID: 34219414
• Alves G, Ogurtsov AY, Porterfield H, Maity T, Jenkins LM, Sacks DB, Yu YK. Multiplexing the Identification of Microorganisms via Tandem Mass Tag Labeling Augmented by Interference Removal through a Novel Modification of the Expectation Maximization Algorithm. J Am Soc Mass Spectrom. 2024 Jun 5;35(6):1138-1155. PubMed PMID: 38740383

Practice Locations

Specialty Information

• Pathology, Board Certification (2017)
• Medical Microbiology, Board Certification (2018)
• Molecular Genetic, Board Certification (2021)